These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5355341)

  • 1. Dopamine (3-hydroxytyramine) metabolism in parkinsonism.
    Goodall M; Alton H
    J Clin Invest; 1969 Dec; 48(12):2300-8. PubMed ID: 5355341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased noradrenaline (norepinephrine) synthesis in familial dysautonomia.
    Goodall MC; Gitlow SE; Alton H
    J Clin Invest; 1971 Dec; 50(12):2734-40. PubMed ID: 5129321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine (3-hydroxytyramine) replacement and metabolism in sympathetic nerve and adrenal medullary depletions after prolonged thermal injury.
    Goodall MC; Alton H
    J Clin Invest; 1969 Sep; 48(9):1761-7. PubMed ID: 5822584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three solvent partition chromatographic technique for the estimation of acid metabolites of catecholamines. Urinary DOMA, DOPAC and HVA.
    Vahidi A; Siva Sankar DV
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):156-60. PubMed ID: 5524313
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of 3-hydroxytyramine (dopamine) in human subjects.
    Goodall M; Alton H
    Biochem Pharmacol; 1968 Jun; 17(6):905-14. PubMed ID: 5661353
    [No Abstract]   [Full Text] [Related]  

  • 6. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cannabis sativa administered by smoking on biogenic amine excretion in man.
    Messiha FS; Soskin RA
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):325-8. PubMed ID: 4734006
    [No Abstract]   [Full Text] [Related]  

  • 8. Catecholamines and their acidic metabolites in urine and in tumour tissue in neuroblastoma, ganglioneuroma and phaeochromocytoma.
    Hinterberger H; Bartholomew RJ
    Clin Chim Acta; 1969 Jan; 23(1):169-75. PubMed ID: 5762125
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary catecholamine excretion by healthy children. I. Daily excretion of dopamine, norepinephrine, epinephrine, and 3-methoxy-4-hydroxymandelic acid.
    Voorhess ML
    Pediatrics; 1967 Feb; 39(2):252-7. PubMed ID: 6017961
    [No Abstract]   [Full Text] [Related]  

  • 11. [The excretion of vanilmandelic acid, vanillic acid, homovanillic acid and 5-hydroxyindoleacetic acid by urine in smokers and non-smokers].
    Schmid E; Tautz NA; Bauersachs E; Krautheim J
    Arzneimittelforschung; 1968 Jul; 18(7):819-21. PubMed ID: 5755826
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism in the human of 3, 4-dihydroxymandelic acid, one of the metabolites of noradrenaline and adrenaline.
    Goodall M; Alton H
    Biochem Pharmacol; 1969 Feb; 18(2):295-302. PubMed ID: 5778148
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.
    Tyce GM; Muenter MD; Owen CA
    Mayo Clin Proc; 1970 Sep; 45(9):645-56. PubMed ID: 5311767
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-related alterations in metabolism of levodopa: possible mechanism for hypotensive effect.
    Kochar MS; Itskovitz HD; Sasse EA; Baker JD; Doumas BT
    J Clin Pharmacol; 1974; 14(8):448-54. PubMed ID: 4851433
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary monoamine metabolites in children with minimal brain dysfunction.
    Wender PH; Epstein RS; Kopin IJ; Gordon EK
    Am J Psychiatry; 1971 Apr; 127(10):1411-5. PubMed ID: 5549938
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased noradrenaline (norepinephrine) synthesis in neurogenic orthostatic hypotension.
    Goodall MC; Harlan WR; Alton H
    Circulation; 1968 Sep; 38(3):592-603. PubMed ID: 5673610
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism of orally administered L-Dopa in Parkinsonism.
    Calne DB; Karoum F; Ruthven CR; Sandler M
    Br J Pharmacol; 1969 Sep; 37(1):57-68. PubMed ID: 5343357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of L-3,4-dihydroxyphenylalanine-2,5,6-3H and 3,4-dihydroxyphenylethylamine-2-14C in a patient with neuroblastoma.
    Imashuku S; LaBrosse EH
    J Clin Endocrinol Metab; 1971 Feb; 32(2):241-53. PubMed ID: 5539035
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary excreion of DOPA and metabolites by patients with melanoma.
    Voorhess ML
    Cancer; 1970 Jul; 26(1):146-9. PubMed ID: 5424526
    [No Abstract]   [Full Text] [Related]  

  • 20. [Catecholamine metabolism in different forms of Parkinson's disease].
    Selikhova MV; Kogan BM; Serkin GV; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):37-40. PubMed ID: 12378880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.